SCHEMBL727295

SCHEMBL727295

N#COC1(OC#N)C=CC(c2ccccc2)C=C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CUL4A Q13619 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5185255 0.75 POLB (0.34)
SCHEMBL1532971 0.73 ALDH1A1 (0.33) CUL4A
SCHEMBL10675226 0.72 CHRNA7 (0.34)
SCHEMBL2428046 0.72 KDM1A (0.34) CUL4A
SCHEMBL3480926 0.71 KDM1A (0.35)
SCHEMBL6056030 0.71
SCHEMBL6634855 0.68
SCHEMBL8407466 0.68 HTR2A (0.33)
SCHEMBL16486982 0.68 ALDH1A1 (0.35)
SCHEMBL7184223 0.68 POLB (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575239-B2 Curing composition and cured product prepared by using the same LG CHEM, LTD. (KR) 2013-11-05 US claimed
EP-2231781-B1 CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME LG CHEMICAL LTD (KR) 2012-09-26 EP claimed
JP-2011525198-A 2011-09-15 JP claimed
US-20100286302-A1 CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME SHANJIN OPTOELECTRONICS (SUZHOU) CO., LTD. (CN) 2010-11-11 US claimed
EP-2231781-A2 CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME LG Chem, Ltd. (KR) 2010-09-29 EP claimed
WO-2009084861-A2 CURING COMPOSITION AND CURED PRODUCT PREPARED BY USING THE SAME LG CHEM, LTD. (KR) 2009-07-09 WO claimed
US-20250382414-A1 RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES UNIV COLORADO REGENTS (US) 2025-12-18 US disclosed
US-20250236693-A1 RESIN COMPOSITION, AND MOLDED PRODUCT, CURED PRODUCT, FILM, COMPOSITE MATERIAL, CURED COMPOSITE MATERIAL, LAMINATE, METAL FOIL WITH RESIN, AND VARNISH FOR CIRCUIT BOARD MATERIAL OBTAINEDTHEREFROM NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2025-07-24 US disclosed
EP-3730552-B1 THERMOSETTING RESIN COMPOSITION TEIJIN LTD (JP) 2025-07-16 EP disclosed
EP-4543964-A1 RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-04-30 EP disclosed
US-20240351981-A1 NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS EVONIK OPERATIONS GMBH (DE) 2024-10-24 US disclosed
EP-4380922-A1 NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS Evonik Operations GmbH (DE) 2024-06-12 EP disclosed
WO-2023250039-A1 RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) 2023-12-28 WO disclosed
EP-0413087-A1 Photosensitive composition and use thereof International Business Machines Corporation (US) 1991-02-20 EP disclosed
EP-0232368-B1 AROMATIC BISMALEIMIDES AND PREPREG RESINS THEREFROM AMOCO CORPORATION (US) 1991-01-16 EP disclosed
EP-0230631-B1 INTERMEDIATE FOR COMPOSITE MATERIAL MITSUBISHI RAYON CO., LTD. (JP) 1990-08-01 EP disclosed
US-4743647-A Prepreg resin from aromatic bismaleimide and ethylenically unsaturated coreactant AMOCO CORPORATION (US) 1988-05-10 US disclosed
EP-0232368-A1 AROMATIC BISMALEIMIDES AND PREPREG RESINS THEREFROM. AMOCO CORP (US) 1987-08-19 EP disclosed
US-4654407-A HIGH STRENGTH CASTINGS AMOCO CORPORATION (US) 1987-03-31 US disclosed
WO-1987000835-A1 AROMATIC BISMALEIMIDES AND PREPREG RESINS THEREFROM AMOCO CORPORATION (US) 1987-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382414-A1 RECYCLABLE AND MALLEABLE THERMOSETS ENABLED BY ACTIVATING DORMANT DYNAMIC LINKAGES CDK4, TRIB2, KDM4B CUL4A 112/4885
US-20240351981-A1 NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS PBRM1, SMCHD1, SMARCE1 CUL4A 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.